%0 Journal Article
%T Cannabidiol's Upregulation of N-acyl Ethanolamines in the Central Nervous System Requires N-acyl Phosphatidyl Ethanolamine-Specific Phospholipase D
%A Emma Leishman
%A Heather B. Bradshaw
%A Ken Mackie
%A Meera Manchanda
%A Rachel Thelen
%A Sally Miller
%J Archive of "Cannabis and Cannabinoid Research".
%D 2018
%R 10.1089/can.2018.0031
%X Introduction: жд9-tetrahydrocannabinol (THC) and cannabidiol (CBD) are bioactive cannabinoids. We recently showed that acute THC administration drives region-dependent changes in the mouse brain lipidome. This study tested the hypothesis that cell lines representing cell types present in the central nervous system (CNS), neurons (N18 cells), astrocytes (C6 glioma cells), and microglia (BV2 cells) would respond differently to THC, CBD, or their combination. This experimental strategy also allowed us to test the hypothesis that THC and CBD are metabolized differently if presented in combination and to test the hypothesis that responses to CBD are not like the fatty acid amide hydrolase (FAAH) inhibitor URB597. Finally, we tested the hypothesis that CBD's CNS effects would differ in the N-acyl phosphatidyl ethanolamine-specific phospholipase D (NAPE-PLD) knockout (KO) compared to wild-type (WT) mice
%K lipidomics
%K CBD
%K N-acyl ethanolamine
%K NAPE-PLD
%K THC
%K FAAH
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6277981/